Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
•To evaluate the humoral immune response induced by the H5N1 vaccine candidate in terms of anti-haemagglutinin antibody titer. •To evaluate the safety and reactogenicity of the H5N1 vaccine candidate in terms of solicited local and general adverse events, unsolicited adverse events and serious adverse events
Critère d'inclusion
- Immunization of healthy children aged 3-9 years against (H5N1) influenza